Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Paul Fields is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Abdul-Jawad, S., Baù, L., Alaguthurai, T., Del Molino Del Barrio, I., Laing, A. G., Hayday, T. S., Monin, L., Muñoz-Ruiz, M., McDonald, L., Francos Quijorna, I., McKenzie, D., Davis, R., Lorenc, A., Chan, J. N. E., Ryan, S., Bugallo-Blanco, E., Yorke, R., Kamdar, S., Fish, M. & Zlatareva, I. & 31 others, , 8 Feb 2021, In: CANCER CELL. 39, 2, p. 257-275.e6Research output: Contribution to journal › Article › peer-review
Open Access96 Citations (Scopus) -
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
McKenzie, D. R., Muñoz-Ruiz, M., Monin, L., Alaguthurai, T., Lechmere, T., Abdul-Jawad, S., Graham, C., Pollock, E., Graham, R., Sychowska, K., Seow, J., Tremain, C., Gousis, C., Domingo-Vila, C., Cooper, J., Vidler, J., Owczarczyk, K., Swampillai, A., Kristeleit, H. & Malim, M. H. & 8 others, , 8 Nov 2021, In: CANCER CELL. 39, 11, p. 1445-1447 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access33 Citations (Scopus) -
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Monin, L., Laing, A. G., Muñoz-Ruiz, M., McKenzie, D. R., Del Molino Del Barrio, I., Alaguthurai, T., Domingo-Vila, C., Hayday, T. S., Graham, C., Seow, J., Abdul-Jawad, S., Kamdar, S., Harvey-Jones, E., Graham, R., Cooper, J., Khan, M., Vidler, J., Kakkassery, H., Sinha, S. & Davis, R. & 24 others, , Jun 2021, In: The Lancet Oncology. 22, 6, p. 765-778 14 p.Research output: Contribution to journal › Article › peer-review
490 Citations (Scopus) -
Factors affecting COVID-19 outcomes in cancer patients from Guy's Cancer Center and King's College Hospital.
Palmer, K., Sylva, R., Russell, B., Moss, C., Shah, V., Ko, T. K., George, G., Kordasti, S., Crawley, D., Wylie, H., Cahill, F., Haire, A., Zaki, K., Sita-Lumsden, A., Josephs, D., Enting, D., Swampillai, A., Sawyer, E., Lei, M. & D'Souza, A. & 8 others, , Mar 2020, In: Clinical Cancer Research. 27, 6Research output: Contribution to journal › Meeting Abstract › peer-review
-
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study
Dhanapal, V., Gunasekara, M., Lianwea, C., Marcus, R., De Lord, C., Bowcock, S., Devereux, S., Patten, P., Yallop, D., Wrench, D., Fields, P. & Kassam, S., 16 Jan 2017, In: Leukemia and Lymphoma. p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus)